Nuvectis Pharma, Inc. (NVCT)

$9.41

+1.43 (+17.92%)
Rating:
Recommendation:
-
Symbol NVCT
Price $9.41
Beta 0.000
Volume Avg. 0.04M
Market Cap 137.786M
Shares () -
52 Week Range 3.08-20.92
1y Target Est -
DCF Unlevered NVCT DCF ->
DCF Levered NVCT LDCF ->
ROE -232.73% Strong Sell
ROA -82.89% Strong Sell
Operating Margin -
Debt / Equity 22.05% Neutral
P/E -
P/B 6.49 Strong Buy
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest NVCT news


Healthcare
Biotechnology
NASDAQ Capital Market

Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. It develops NXP800, a novel heat shock factor 1 pathway inhibitor for the treatment of various cancers; and NXP900, a small molecule drug candidate to inhibit the Proto-oncogene c-Src and YES1 kinases. The company was incorporated in 2020 and is based in Fort Lee, New Jersey.